We found that the tumor cells of HCC patients have significantly higher ABCG2 than the adjacent normal liver tissues, while the cells of sorafenib-resistant HCC patients expressed the highest ABCG2 (Fig. 1b). Here, ABCG2 is linked to hepatocellular carcinoma.